Stay updated with breaking news from Pascal Precision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Deal Overview On December 7, 2024, Edwards Lifesciences Corporation (NYSE: EW, $76.90, Market Capitalization: $46.6 billion) in its annual investor call announced its ...
Edwards Lifesciences reported Q3 results that met Wall Street expectations. It remains on track to boost sales by up to 13% this year.
Edwards Lifesciences (NYSE: EW) shares fell after hours today despite second-quarter results that beat the consensus forecast.
As earnings season is upon us, we're receiving a clearer view of what new medtech could be launching this year in the medical device space.
Edwards Lifesciences (NYSE:EW) announced today that Michael A. Mussallem, chair and CEO, intends to retire next year.